NCT06309992: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)

Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Obesity, Non-Alcoholic SteatoHepatitis (NASH)